Biotech BrothersRing Therapeutics Raises $117 Million in Series B FinancingRing Therapeutics, a life sciences firm established by Flagship Pioneering to transform gene therapy with its commensal virome platform…Aug 8, 2021Aug 8, 2021
Biotech BrothersFDA Approves Nexviazyme For Pompe DiseaseOn August 6, 2021, the U.S. Food and Drug Administration announced it has approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous…Aug 8, 2021Aug 8, 2021
Biotech BrothersAmgen Acquires Teneobio For $900 Million 💸Amgen and Teneobio on July 27, 2021 announced they had reached an agreement which will see Amgen acquire Teneobio, a privately held…Aug 7, 2021Aug 7, 2021
Biotech BrothersSEC Mandates Chinese IPO Hopefuls to Provide Additional Risk DisclosuresThe U.S. securities regulator in an exclusive report released on July 30 says it will not allow Chinese companies to undertake fundraising…Aug 4, 2021Aug 4, 2021
Biotech BrothersIs there ample proof that Biogen’s new Alzheimer’s med Aduhelm is beneficial to patients…During a daylong meeting Thursday involving debate over the drug’s costs and other issues, experts voted 15 to 0 that Aduhelm doesn’t…Aug 3, 2021Aug 3, 2021
Biotech BrothersICER Rejects Aduhelm’s Benefits Over SOC to PatientsIs there ample proof that Biogen’s new Alzheimer’s med Aduhelm is beneficial to patients, physicians and society beyond the existing…Jul 24, 2021Jul 24, 2021
Biotech BrothersLilly Drives Access to Covid Antibodies with Infusion CentersEli Lilly’s Covid-19 monoclonal antibody isn’t getting as much use as it could as a result of logistical issues. So the drugmaker is…Feb 5, 2021Feb 5, 2021
Biotech BrothersShark Tank’s Mark Cuban Launches Generics Maker Promising ‘Radically’ Low-Cost DrugsBillionaire investor Mark Cuban is renowned for critiquing startup plans on the hit TV series ‘Shark Tank,” often dismissing prospective…Jan 28, 2021Jan 28, 2021
Biotech BrothersRegeneron Signs Big New Coronavirus Antibody Supply Deal Worth up to $2.6 billionPharma companies globally scrambled to respond to the Covid-19 pandemic in early 2020, but so far only a handful have advanced therapies…Jan 26, 2021Jan 26, 2021
Biotech BrothersMerck Looks For FDA Review for 15-strain Pneumonia VaccinePrevnar 13, Pfizer’s $5.8 billion-a-year vaccine is unarguably one of the firm’s top blockbusters and the undisputed leader in the…Jan 14, 2021Jan 14, 2021
